Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Molecular Endocrinology Laboratory, |
RCV001823855 | SCV002073523 | uncertain significance | Obesity | criteria provided, single submitter | clinical testing | ||
Institute of Human Genetics, |
RCV001823855 | SCV002505559 | uncertain significance | Obesity | 2022-03-21 | criteria provided, single submitter | clinical testing | _x000D_ Criteria applied: PM2_SUP, PP3 |
Ambry Genetics | RCV004041005 | SCV003862916 | uncertain significance | not specified | 2023-02-14 | criteria provided, single submitter | clinical testing | The c.712C>T (p.R238C) alteration is located in exon 2 (coding exon 2) of the NR0B2 gene. This alteration results from a C to T substitution at nucleotide position 712, causing the arginine (R) at amino acid position 238 to be replaced by a cysteine (C). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Institute of Human Genetics, |
RCV004762193 | SCV005368078 | uncertain significance | Inherited obesity | 2022-03-31 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV003892880 | SCV004717959 | uncertain significance | NR0B2-related disorder | 2024-01-30 | no assertion criteria provided | clinical testing | The NR0B2 c.712C>T variant is predicted to result in the amino acid substitution p.Arg238Cys. To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.046% of alleles in individuals of South Asian descent in gnomAD. At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. |